SLADA conducts doping test results management in a reliable and impartial manner in compliance with national and international standards. SLADA is responsible for results management within the scope of the national testing programme. The laboratory that analysed the doping test samples informs SLADA of the results of all doping test samples in a reliable and confidential manner.
Based on the doping test records and the laboratory’s doping test result documentation, SLADA identifies athletes who have given a negative doping test sample. If necessary, SLADA informs the involved parties of the negative samples in accordance with the anti doping codes. Athletes are not usually separately informed of negative test results.
If an athlete’s doping test result (A-sample) is an adverse analytical finding (positive), SLADA reviews whether the athlete has a valid TUE regarding the substance that caused the adverse analytical finding or whether such a TUE can be granted to the athlete retroactively on the basis of Sri Lanka anti doping code and the International Standard for Therapeutic Use Exemptions. SLADA will also review whether the Adverse Analytical Finding could have been caused by a departure from the International Standard for Testing and Investigations or the International Standard for Laboratories. If the athlete has a valid TUE or one can be granted retroactively, SLADA will not continue the management of the doping test result as an adverse analytical finding.
If the preliminary assessment establishes that the athlete has not been granted a TUE and that one cannot be granted retroactively, SLADA will send the athlete a request for a statement. This information will also be delivered to the athlete’s sports federation, and any other parties required by the anti doping code.
The athlete, the relevant federation and SLADA are, within the deadline stated in the request for statement, entitled to request the analysis of the B sample. The request must be presented in writing or in another verifiable manner. If the analysis of the B sample is not provided within the stated deadline, it is considered that the right to the analysis of the B sample has been waived.
Among other things, SLADA performs the additional investigations required for investigating a suspected anti doping rule violation with the procedures it sees appropriate and necessary. If SLADA has justified grounds for considering that an anti doping rule violation has taken place (such as an athlete refusing to be tested for doping, or possession of doping substances, atypical passport finding, complicity or forbidden collaboration), it will immediately notify the suspected athlete or other person in writing about the section of the code that has probably been violated and the grounds of the violation.
SLADA will request the person in question and relevant sports federation or other party to provide a written statement on the matter and inform about the opportunity to be present at an inquiry meeting to be heard prior to decision-making on whether the person in question is guilty of a violation of anti doping rules.
SLADA either on its own initiative or when voluntarily requested by an athlete, may impose a Provisional Suspension on an athlete, as provided for in the code, after having been informed of an Adverse Analytical Finding and deciding to present a positive test result as a potential antidoping rule violation or being informed of any other potential antidoping rule violation.
However, an Adverse Analytical Finding will not be deemed an antidoping rule violation until the SLADA as well as the sports organisation in question have processed the case and issued a decision. The athlete’s legal protection must therefore be respected by keeping the case confidential until the final decision is made. Only the athlete himself or herself can make the matter public before the final decision.
When SLADA informs an athlete or another person or relevant sports federation of a positive test result or suspected other antidoping rule violation, the athlete and/or relevant party may submit their written statement on the matter and a written request to be heard at the meeting of the disciplinary panel either within seven (7) days of receiving notice of the request for a statement, or, if the analysis of the B sample was requested, within seven (7) days of having received notice of the analysis result.
Not issuing a written statement or the absence of the person or other relevant party are no impediments to the review and resolution of the matter by the disciplinary panel.
The athlete, a representative authorised by the athlete in writing, another person or relevant sports federation or other sport organisation considered relevant may, for a special reason, request additional time for providing a statement. The Chair of the disciplinary panel or, if he or she is unable to do so, a member decides on extending the deadline.
The disciplinary panel of SLADA will process the case and decide whether the action of an athlete or another person falling within the scope of application of the code is to be regarded as an antidoping rule violation under the code. If the disciplinary panel is of the opinion that an antidoping rule violation has taken place, it will issue a reasoned statement of the sanction recommended by it that should be imposed for the violation pursuant to the code. In accordance with the antidoping code adopted by sports organisations, however, the federation shall decide on the final sanction for the antidoping rule violation and notify without delay about the antidoping violation and the sanction imposed in a manner specified in the Antidoping Code.
An athlete or representative authorised by him or her in writing, SLADA and the relevant sports federation or other competent sport organisation have the right to request that the B sample be analysed within the provided deadline. The B sample analysis is carried out at the expense of the party requesting the analysis. The request for analysis must be presented in writing or in another verifiable manner. If the analysis of the B sample is not provided within the stated deadline, it is considered that the analysis of the B sample has been waived.
If the analysis result of the B sample does not confirm the positive doping test result of the A sample, the entire doping test is considered to be negative, and the case will no longer be considered a potential antidoping rule violation.
If the analysis result of the B sample confirms the positive doping test result of the A sample, SLADA will continue to manage the case as a potential antidoping rule violation and notify the athlete and other persons and parties informed of the result of the A sample of continued processing of the case.